Developer docs
API playgroundTry for free, no card

Search company profiles

Xi'an Beilin Pharmaceutical Co.

Full company profile

uuid0033amu

Namestring
Xi'an Beilin Pharmaceutical Co.
Legal namestring
远大碑林(西安)药业有限公司
Websiteurl
beilinchina.cn
Company typeenum
Private
Founded yearint
1969
Descriptiontext

Xi'an Beilin Pharmaceutical Co., Ltd. (远大碑林(西安)药业有限公司) is a privately-held Chinese pharmaceutical manufacturer founded in 1969 and headquartered in Xi'an, Shaanxi Province. The company produces traditional Chinese medicines (TCM) and health supplements targeting a range of consumer health needs, operating under the long-standing Beilin (碑林) brand alongside the DBA 远大碑林药业 (Yuanda Beilin Pharmaceutical). The '远大' (Yuanda) prefix in the corporate name suggests potential affiliation with a larger Yuanda group, though no formal parent-subsidiary relationship, ownership structure, or capital structure is documented in available sources. The company maintains a workforce of 1,001-5,000 employees, indicating mid-sized manufacturing operations with established production capacity.

The company operates an active corporate website (beilinchina.cn) that surfaces a Products and Services section and a News section, although specific product names, formulations, therapeutic indications, technical manufacturing details, certifications, and pipeline information are not disclosed in the available source material. As a TCM producer, the company's operational backbone likely rests on regulated pharmaceutical manufacturing licenses, traditional formulation expertise, and brand equity built over more than five decades. The website's template-based structure and absence of disclosed product detail suggest a relatively traditional offline-anchored distribution model rather than a digitally-led consumer brand.

The business model of a mid-sized Chinese TCM manufacturer typically combines branded OTC pharmacy distribution, hospital channel sales, and selective e-commerce presence, with revenue mechanics driven by unit volume across therapeutic categories rather than enterprise contracts. However, no revenue figures, pricing tiers, go-to-market specifics, customer segments, or geographic distribution data are publicly disclosed. Ownership remains opaque with no disclosed funding rounds, M&A activity, leadership changes, or strategic milestones in the available data. The website appears active, indicating ongoing operations, but there is no public information on recent commercial initiatives to triangulate competitive positioning or growth direction.

Short descriptiontext

Xi'an Beilin Pharmaceutical Co., founded in 1969, is a privately-held Chinese manufacturer of traditional Chinese medicines and health supplements, headquartered in Xi'an with 1,001-5,000 employees, serving consumer health needs through its long-established Beilin brand.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersXian Shi, China
HQ citystring
Xian Shi
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
traditional Chinese medicine, herbal medicine manufacturing, health supplements, pharmaceutical manufacturing, OTC medicine production
Industry1 code
1Generic Finished Dosage Form (FDF) Manufacturing
CodeHLAIABAHPrimaryYes
NAICS code4 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical and Medicine Manufacturing3254
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Traditional Chinese Medicine Manufacturing
No data
Cost components4 values
Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Xi'an Beilin Pharmaceutical Co. is a Chinese pharmaceutical manufacturer that produces and sells traditional Chinese medicines and herbal health supplements under the Beilin (碑林) brand. Founded in 1969 and based in Xi'an, Shaanxi Province, the company operates manufacturing facilities staffed by 1,001–5,000 employees to serve domestic pharmaceutical and consumer health markets in China.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

远大碑林(西安)药业有限公司 (Yuanda Beilin (Xi'an) Pharmaceutical Co., Ltd.) operates a website at https://beilinchina.cn/ featuring a Products and Services section and News section. The source content contains primarily template placeholders with no specific product names, detailed descriptions, or architectural information available for extraction.

Product and service2 records
1Traditional Chinese Medicines
CategoryTraditional Chinese Medicine
Description

Branded traditional Chinese medicine formulations manufactured by Xi'an Beilin Pharmaceutical Co. and sold under the Beilin (碑林) name for treatment of common ailments and traditional therapeutic indications. Targeted at domestic Chinese distributors, hospital and retail pharmacies, and end consumers.

2Herbal Health Supplements
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Chinese pharmaceutical group combining TCM, chemical drugs, and APIs. Comparable as a diversified manufacturer with a meaningful TCM franchise alongside broader pharmaceutical operations.

TypeDirect peer
Description

One of China's largest TCM manufacturers, producing proprietary Chinese medicines and health products. Directly comparable as a branded TCM manufacturer with established domestic scale and growing consumer health reach.

3China Beijing Tongrentang (Group)
TypeDirect peer
Description

Iconic TCM manufacturer with a 350+ year heritage, producing classical Chinese medicines and health products. Comparable as a long-established branded TCM player with strong domestic and growing international footprint.

4Jiangsu Yangtze River Pharmaceutical (Yangzi River Pharma)
TypeBroad incumbent
Description

Large privately-held Chinese pharmaceutical manufacturer with both TCM and chemical drug operations. Comparable in scale and domestic manufacturing footprint to a mid-tier TCM player like Beilin.

TypeBroad incumbent
Description

State-backed pharmaceutical conglomerate with TCM and western medicine manufacturing. Comparable as a diversified large-scale player covering the same regulatory and distribution environment as Beilin.

TypeDirect peer
Description

Specialty TCM manufacturer known for a single flagship formula, but operating in the same branded Chinese medicine manufacturing space with similar regulatory and distribution dynamics.

TypeDirect peer
Description

Vertically integrated TCM manufacturer specializing in ejiao and related healthcare products. Comparable as a heritage Chinese medicine producer with branded consumer health positioning.

TypeDirect peer
Description

Major Chinese TCM and chemical drug manufacturer, with brands including Huangshangji and Wanglaoji. Comparable as a scaled TCM producer operating in both pharmaceutical and consumer health categories.

TypeBroad incumbent
Description

One of China's largest pharmaceutical conglomerates with a significant TCM franchise. Comparable as a broad incumbent operating Chinese medicine manufacturing as part of a wider prescription and consumer health portfolio.

TypeDirect peer
Description

TCM innovator focused on cardiology and oncology formulas; comparable to Beilin as a mid-large traditional Chinese medicine manufacturer transitioning toward evidence-based modernized formulations.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Xi'an Beilin Pharmaceutical Co.

Traditional Chinese Medicine Manufacturingbeilinchina.cn

Xi'an Beilin Pharmaceutical Co., founded in 1969, is a privately-held Chinese manufacturer of traditional Chinese medicines and health supplements, headquartered in Xi'an with 1,001-5,000 employees, serving consumer health needs through its long-established Beilin brand.

What Xi'an Beilin Pharmaceutical Co. does

Xi'an Beilin Pharmaceutical Co., Ltd. (远大碑林(西安)药业有限公司) is a privately-held Chinese pharmaceutical manufacturer founded in 1969 and headquartered in Xi'an, Shaanxi Province. The company produces traditional Chinese medicines (TCM) and health supplements targeting a range of consumer health needs, operating under the long-standing Beilin (碑林) brand alongside the DBA 远大碑林药业 (Yuanda Beilin Pharmaceutical). The '远大' (Yuanda) prefix in the corporate name suggests potential affiliation with a larger Yuanda group, though no formal parent-subsidiary relationship, ownership structure, or capital structure is documented in available sources. The company maintains a workforce of 1,001-5,000 employees, indicating mid-sized manufacturing operations with established production capacity.

The company operates an active corporate website (beilinchina.cn) that surfaces a Products and Services section and a News section, although specific product names, formulations, therapeutic indications, technical manufacturing details, certifications, and pipeline information are not disclosed in the available source material. As a TCM producer, the company's operational backbone likely rests on regulated pharmaceutical manufacturing licenses, traditional formulation expertise, and brand equity built over more than five decades. The website's template-based structure and absence of disclosed product detail suggest a relatively traditional offline-anchored distribution model rather than a digitally-led consumer brand.

The business model of a mid-sized Chinese TCM manufacturer typically combines branded OTC pharmacy distribution, hospital channel sales, and selective e-commerce presence, with revenue mechanics driven by unit volume across therapeutic categories rather than enterprise contracts. However, no revenue figures, pricing tiers, go-to-market specifics, customer segments, or geographic distribution data are publicly disclosed. Ownership remains opaque with no disclosed funding rounds, M&A activity, leadership changes, or strategic milestones in the available data. The website appears active, indicating ongoing operations, but there is no public information on recent commercial initiatives to triangulate competitive positioning or growth direction.

Xi'an Beilin Pharmaceutical Co. firmographics

Firmographics
Name
Xi'an Beilin Pharmaceutical Co.
Legal name
远大碑林(西安)药业有限公司
Website
https://beilinchina.cn
Company type
Private
Founded year
1969
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Xi'an Beilin Pharmaceutical Co., founded in 1969, is a privately-held Chinese manufacturer of traditional Chinese medicines and health supplements, headquartered in Xi'an with 1,001-5,000 employees, serving consumer health needs through its long-established Beilin brand.
Ownership category
akta.pro rank

Xi'an Beilin Pharmaceutical Co. industry classification

Industry
Product category
Traditional Chinese Medicine Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

  • Traditional Chinese medicine
  • Herbal medicine manufacturing
  • Health supplements
  • Pharmaceutical manufacturing
  • OTC medicine production

Where Xi'an Beilin Pharmaceutical Co. is headquartered

Location

Headquarters

HQ city
Xian Shi
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Xi'an Beilin Pharmaceutical Co. business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales

Xi'an Beilin Pharmaceutical Co. product offering

Product offering

Core offering

Xi'an Beilin Pharmaceutical Co. is a Chinese pharmaceutical manufacturer that produces and sells traditional Chinese medicines and herbal health supplements under the Beilin (碑林) brand. Founded in 1969 and based in Xi'an, Shaanxi Province, the company operates manufacturing facilities staffed by 1,001–5,000 employees to serve domestic pharmaceutical and consumer health markets in China.

Product overview

远大碑林(西安)药业有限公司 (Yuanda Beilin (Xi'an) Pharmaceutical Co., Ltd.) operates a website at https://beilinchina.cn/ featuring a Products and Services section and News section. The source content contains primarily template placeholders with no specific product names, detailed descriptions, or architectural information available for extraction.

Differentiator

Problem solved

Functional benefit

Products and services

  • Traditional Chinese Medicines Branded traditional Chinese medicine formulations manufactured by Xi'an Beilin Pharmaceutical Co. and sold under the Beilin (碑林) name for treatment of common ailments and traditional therapeutic indications. Targeted at domestic Chinese distributors, hospital and retail pharmacies, and end consumers.
  • Herbal Health Supplements

Companies that use Xi'an Beilin Pharmaceutical Co.

Customer profile

Ideal customer profiles2 records

Xi'an Beilin Pharmaceutical Co. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Xi'an Beilin Pharmaceutical Co. partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Xi'an Beilin Pharmaceutical Co. competitors and assessment

Company assessment

Direct peers

  • Livzon Pharmaceutical Group: Chinese pharmaceutical group combining TCM, chemical drugs, and APIs. Comparable as a diversified manufacturer with a meaningful TCM franchise alongside broader pharmaceutical operations.
  • Yunnan Baiyao Group: One of China's largest TCM manufacturers, producing proprietary Chinese medicines and health products. Directly comparable as a branded TCM manufacturer with established domestic scale and growing consumer health reach.
  • China Beijing Tongrentang (Group): Iconic TCM manufacturer with a 350+ year heritage, producing classical Chinese medicines and health products. Comparable as a long-established branded TCM player with strong domestic and growing international footprint.
  • Pien Tze Huang (Pi Zhu Tang): Specialty TCM manufacturer known for a single flagship formula, but operating in the same branded Chinese medicine manufacturing space with similar regulatory and distribution dynamics.
  • Shandong Dong-E E-Jiao: Vertically integrated TCM manufacturer specializing in ejiao and related healthcare products. Comparable as a heritage Chinese medicine producer with branded consumer health positioning.
  • Guangzhou Pharmaceutical Holdings (GPHL / Huangshangji): Major Chinese TCM and chemical drug manufacturer, with brands including Huangshangji and Wanglaoji. Comparable as a scaled TCM producer operating in both pharmaceutical and consumer health categories.
  • Yiling Pharmaceutical (Shijiazhuang Yiling): TCM innovator focused on cardiology and oncology formulas; comparable to Beilin as a mid-large traditional Chinese medicine manufacturer transitioning toward evidence-based modernized formulations.

Broad incumbents

  • Jiangsu Yangtze River Pharmaceutical (Yangzi River Pharma): Large privately-held Chinese pharmaceutical manufacturer with both TCM and chemical drug operations. Comparable in scale and domestic manufacturing footprint to a mid-tier TCM player like Beilin.
  • China Resources Pharmaceutical Group: State-backed pharmaceutical conglomerate with TCM and western medicine manufacturing. Comparable as a diversified large-scale player covering the same regulatory and distribution environment as Beilin.
  • Shanghai Pharmaceuticals Holding: One of China's largest pharmaceutical conglomerates with a significant TCM franchise. Comparable as a broad incumbent operating Chinese medicine manufacturing as part of a wider prescription and consumer health portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Xi'an Beilin Pharmaceutical Co. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xi'an Beilin Pharmaceutical Co. leadership team

Management profile

Number of profiles

Xi'an Beilin Pharmaceutical Co. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xi'an Beilin Pharmaceutical Co. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xi'an Beilin Pharmaceutical Co.

What does Xi'an Beilin Pharmaceutical Co. do?

Xi'an Beilin Pharmaceutical Co. is a Chinese pharmaceutical manufacturer that produces and sells traditional Chinese medicines and herbal health supplements under the Beilin (碑林) brand. Founded in 1969 and based in Xi'an, Shaanxi Province, the company operates manufacturing facilities staffed by 1,001–5,000 employees to serve domestic pharmaceutical and consumer health markets in China.

When was Xi'an Beilin Pharmaceutical Co. founded?

Xi'an Beilin Pharmaceutical Co. was founded in 1969. It employs 1,001 to 5,000 people.

Where is Xi'an Beilin Pharmaceutical Co. based?

Xi'an Beilin Pharmaceutical Co. is headquartered in Xian Shi, China, in the Asia region.

Who are Xi'an Beilin Pharmaceutical Co.'s main competitors?

Direct peers on record are Livzon Pharmaceutical Group, Yunnan Baiyao Group, China Beijing Tongrentang (Group), Pien Tze Huang (Pi Zhu Tang), Shandong Dong-E E-Jiao, Guangzhou Pharmaceutical Holdings (GPHL / Huangshangji) and Yiling Pharmaceutical (Shijiazhuang Yiling). Broad incumbents are Jiangsu Yangtze River Pharmaceutical (Yangzi River Pharma), China Resources Pharmaceutical Group and Shanghai Pharmaceuticals Holding.

Does Xi'an Beilin Pharmaceutical Co. have an API?

No public API is recorded for Xi'an Beilin Pharmaceutical Co..

What industry is Xi'an Beilin Pharmaceutical Co. in?

Xi'an Beilin Pharmaceutical Co.'s product category is Traditional Chinese Medicine Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales